Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

NCT02807857 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02807857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
Lead sponsor
Novartis Pharmaceuticals
Phase
Not applicable
Overall status
Completed
Start date
July 7, 2016
Completion date
March 23, 2018
Enrollment
1,415 (actual)
Sites
191

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure (chf)